Acute Myocarditis Following COVID-19 Vaccination in a Young Adult.
| Autor: | Singh PV; Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA., Izquierdo SA; College of Medicine, St. George's University, St. George's, GRD., Ekasi S; Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA., Schnepp T; College of Medicine, Ross University School of Medicine, Bridgetown, BRB., Rabanal C; College of Medicine, University of Medicine and Health Sciences, Camps, KNA., Olimba LJA; Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA., Dickinson M; Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Dec 15; Vol. 15 (12), pp. e50592. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.50592 |
| Abstrakt: | The mRNA vaccines for coronavirus disease-2019 (COVID-19) have been implemented across the globe for both emergent and non-emergent applications. We present a rare case of myocarditis following the second dosage of COVID-19 vaccine. In this case, myocarditis was suspected by troponin and erythrocyte sedimentation rate (ESR) levels prior to echocardiography, which demonstrated mild pericardial effusion, mild tricuspid regurgitation, and mild asymmetric left ventricular hypertrophy. Mild to moderate symptoms of myocardial inflammation persisted throughout the patient's admission, which attributed to the clinical presentation of chest pain and palpitations. As the patient had no relevant history to account for cardiac pathologies prior to vaccination, this case report serves to further investigate the association between mRNA-derived vaccination and subsequent acute myocarditis development. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Singh et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|